skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Informa pharma logo

ファーマインテリジェンスはInforma PLCのインフォーマインテリジェンス部門の一部です

This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Pharma Intelligence Logo
Search Icon レポートストアメルマガ登録製品ログインProductLogin
Global Search Configuration
  • Close Icon

About Ashley

UK

+20 year(s) experience

Ashley Yeo
Ashley Yeo delivers content that gives insight into current and future trends in the global medtech industry, and what players need to do, and with whom, to keep ahead of the game in this fast-evolving and highly competitive sector. He currently writes for In Vivo and Medtech Insight as an Executive Editor.
Ashley has been with Informa and legacy publications, reporting on all forms of healthcare (plant, animal, human) for over 30 years, having joined as a linguist on the European desk and later becoming editor of three diverse publications. He has also contributed aesthetic medicine and pharma content when a member of the multifunctional team of pharma analysts. His current focus is the strategic rationale of the big players in medtech, on In Vivo; and UK, European and OUS global regulation and policy input on Medtech Insight.
 

Specialties

  • Diagnostics
  • Market Access
  • Policy & Regulation
  • Pricing & Reimbursement

Ashley Writes For

Analyst Articles

Articles by Sue